Clinical Efficacy and Safety of a Modified Moxibustion Therapy for Low Back Pain in Lumbar Disc Herniation: A Two-Center, Randomized, Controlled, Non-Inferiority Trial
Kaiyang Xue,Xianzhu Wang,Caihong Xiao,Ning Zhang,Minghui Liu,Jing Fu,Jin Cui
DOI: https://doi.org/10.2147/jpr.s457724
IF: 2.8319
2024-05-24
Journal of Pain Research
Abstract:Kaiyang Xue, 1 Xianzhu Wang, 1 Caihong Xiao, 2 Ning Zhang, 1 Minghui Liu, 3 Jing Fu, 1 Jin Cui 1 1 College of Acupuncture and Massage, Guizhou University of Traditional Chinese Medicine, Guiyang, 550002, People's Republic of China; 2 Department of Acupuncture and Moxibustion, No.1 Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, 550001, People's Republic of China; 3 Department of Acupuncture and Moxibustion, No.2 Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, 550001, People's Republic of China Correspondence: Jin Cui, College of Acupuncture and Massage, Guizhou University of Traditional Chinese Medicine, No. 50 Shidong Road, Nanming District, Guiyang, 550002, People's Republic of China, Email Objective: Our pilot study shows that a modified moxibustion therapy called Ma's bamboo-based medicinal moxibustion can alleviate the symptoms of low back pain in lumbar disc herniation (LDH), and has the potential to treat LDH. The aim of this study is to evaluate the efficacy and safety of Ma's bamboo-based medicinal moxibustion for low back pain in LDH. Methods: A total of 312 LDH patients with low back pain were randomized to receive Ma's bamboo-based medicinal moxibustion (MBMM) or acupuncture (AT). The primary efficacy measure was the change of Visual Analogue Scale (VAS) on the 14th day compared with that at baseline. The secondary efficacy measures included VAS score, Oswestry disability index (ODI), modified Japanese Orthopaedic Association (M-JOA) score, and the content of β-endorphin (β-EP) and substance-P (SP). The safety measures included the occurrence of adverse events and the changes in laboratory indicators. Results: In total, 304 patients were incorporated for the analysis of efficacy, including 96 males and 208 females, aged 21– 65 years. There was no statistically significant difference in the change of VAS score between the two groups on the 14th day [mean difference (95% CI) = − 2.31 (− 2.48, − 2.13) and − 2.28 (− 2.45, − 2.11), respectively; p = 0.819]. The VAS, ODI, and M-JOA scores changed after the intervention in both groups ( p < 0.001), with increased β-EP content ( p = 0.014, p = 0.032) and decreased SP content ( p < 0.001, p = 0.048). The ODI score ( p = 0.039) and M-JOA score ( p = 0.032) of the MBMM group on the 28th day were lower than those of the AT group. Conclusion: The efficacy of Ma's bamboo-based medicinal moxibustion therapy in relieving low back pain of LDH patients is comparable to that of acupuncture, and it has post-effect advantages in improving lumbar dysfunction and daily living ability, which can be used as a safe and effective alternative method for LDH treatment. Keywords: LDH, low back pain, Ma's bamboo-based medicinal moxibustion, acupuncture, randomized controlled trial LDH refers to a clinical syndrome in which the nucleus pulposus migrates through the damaged annulus fibrosus and protrudes around due to external force or intervertebral disc degeneration to compress and stimulate the nerve root or spinal cord, inducing symptoms such as low back pain, sciatica, lower limb sensory disturbance, etc. 1 LDH has a prevalence of about 1% and involves L4/5 and L5/S1 segments commonly. 2 Low back pain is the initial and main symptom of LDH, 3 as well as the leading cause of disability and decreased productivity worldwide, 4 and LDH has been recognized to be the most common disease causing low back pain. 5 Therefore, the occurrence of LDH may induce huge individual, family, and socioeconomic burden. At present, it is believed that the pathogenesis of LDH may be explained by mechanical compression, inflammatory stimulation, and autoimmune reaction. 6 It can be induced and aggravated by genetic factors, trauma, smoking, obesity, pregnancy, long-term unreasonable exercise, etc. 7 Surgery for LDH is necessary when the symptoms are not significantly improved after continuous conservative treatment. However, there may be postoperative intractable complications such as unstable spinal force line, recurrent protrusion, and pain. 8 Currently, it is believed that only 1–5% of patients need surgical treatment, 9 about 15–25% of which still have symptoms of low back pain after surgery. 10 Therefore, conservative treatment such as exercise, manual therapy, spinal traction, physical therapy, oral medicine (anti-inflammatory and analgesic, neurotrophic treatment), and epidural steroid injection are widely considered as the first therapeutic option for LDH. 11– -Abstract Truncated-
clinical neurology